Home » Newsletters » BioWorld

BioWorld

Sep. 27, 1991

View Archived Issues

ANALYST DOWNPLAYS GM-CSF PATENT NEWS

CHIRON/CETUS MERGER PASSES FTC DEADLINE

CENTOCOR RAISES SIZE OF DEBENTURES

EPITOPE GETS GRANT FOR HIV TEST

MGI GETS RIGHTS TO PILOCARPINE MOUTHWASH

HEMACARE EXTENDS WARRANT EXPIRATION

OXFORD COMPLETES $8M FINANCING

SBIR GRANTED FOR AMYLIN MABS

FDA PANEL RECOMMENDATION SPURS CHIRON

SUITS OPPOSE GI MERGER WITH AHP

COMBINATION TEST APPROVED FOR HIV-1, 2

MULTIDRUG STRATEGY TO COMBAT AIDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...